Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)

NCT04896073 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

NIH

Sponsor class

Conditions

Adenosquamous Carcinoma of the Pancreas

Interventions

DRUG: Minnelide
DIAGNOSTIC_TEST: ECG
DIAGNOSTIC_TEST: CT/MRI
PROCEDURE: Tumor Biopsy

Sponsor

National Cancer Institute (NCI)